 | Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Gap Down to $16.96
americanbankingnews.com - May 10 at 4:38 PM |
| Zacks: Analysts Anticipate Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) to Post -$0.64 EPS
americanbankingnews.com - May 10 at 12:00 PM |
| Crinetics Pharmaceuticals (NASDAQ:CRNX) Now Covered by Jonestrading
americanbankingnews.com - May 10 at 8:36 AM |
| FY2022 Earnings Forecast for Crinetics Pharmaceuticals, Inc. Issued By Cantor Fitzgerald (NASDAQ:CRNX)
americanbankingnews.com - May 9 at 3:40 AM |
| Crinetics Pharmaceuticals (NASDAQ:CRNX) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS
americanbankingnews.com - May 7 at 3:14 PM |
| Cantor Fitzgerald Comments on Crinetics Pharmaceuticals, Inc.'s FY2022 Earnings (NASDAQ:CRNX)
americanbankingnews.com - May 7 at 9:24 AM |
 | Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
in.finance.yahoo.com - May 6 at 7:22 PM |
| Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 6 at 7:22 PM |
| Crinetics Pharmaceuticals (NASDAQ:CRNX) Research Coverage Started at Jonestrading
americanbankingnews.com - May 3 at 1:22 PM |
| Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - May 3 at 9:14 AM |
|
| Brokerages Anticipate Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) to Announce -$0.65 Earnings Per Share
americanbankingnews.com - April 23 at 12:16 AM |
| Crinetics Pharmaceuticals Stock Is Showing Strong Insider Interest
finance.yahoo.com - April 21 at 1:34 PM |
| Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Gap Up to $16.55
americanbankingnews.com - April 21 at 12:54 PM |
| What Type Of Shareholders Own The Most Number of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares?
finance.yahoo.com - April 12 at 8:50 AM |
 | Insider Buys Crinetics Pharmaceuticals Shares
benzinga.com - April 9 at 1:25 PM |
 | Crinetics Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 31 at 12:35 AM |
| Crinetics Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - March 30 at 6:32 PM |
| Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 30 at 6:32 PM |
| Crinetics Pharmaceuticals to Host Webcast and Conference Call to Discuss 2021 Clinical Plans and Fourth Quarter and Full Year 2020 Financial Results
benzinga.com - March 24 at 7:35 AM |
| Crinetics Pharmaceuticals Showcasing Breadth of Pipeline at ENDO 2021 with Presentations on Three Clinical Programs
finance.yahoo.com - March 12 at 4:56 PM |
| Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing's Disease (CRN04894) Advances into Phase 1 Study
benzinga.com - February 5 at 6:35 PM |
| Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study
finance.yahoo.com - February 4 at 7:55 AM |
 | Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
markets.businessinsider.com - February 3 at 9:57 AM |
| Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
finance.yahoo.com - February 3 at 9:57 AM |
 | Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference
theglobeandmail.com - January 7 at 7:09 PM |
| Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 7:53 AM |
| Here's Why We're Not Too Worried About Crinetics Pharmaceuticals' (NASDAQ:CRNX) Cash Burn Situation
finance.yahoo.com - December 27 at 9:39 AM |
| Is CRNX A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 12:27 AM |
|
| Crinetics Pharmaceuticals to Participate in December Investor Conferences
finance.yahoo.com - November 23 at 8:37 AM |
| Crinetics Pharmaceuticals Appoints Acromegaly Expert, Peter Trainer, Vice President of Clinical Endocrinology
finance.yahoo.com - November 16 at 8:22 AM |
| Crinetics Hosting Key Opinion Leader Meeting Focusing on Oral Paltusotine for the Treatment of Acromegaly
finance.yahoo.com - November 13 at 12:31 PM |
| Should You Buy Crinetics Pharmaceuticals (CRNX) Ahead of Earnings?
finance.yahoo.com - November 9 at 2:10 PM |
| Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 6 at 9:29 AM |
| Crinetics Pharmaceuticals Announces Phase 2 ACROBAT Edge Study with Paltusotine in Acromegaly Met Primary Endpoint
finance.yahoo.com - October 26 at 7:12 AM |
| Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism
finance.yahoo.com - September 21 at 8:38 AM |
| Crinetics Pharma to advance ACTH antagonist candidate into the clinic
seekingalpha.com - September 4 at 12:18 PM |
| Crinetics Pharmaceuticals Provides New Data from Paltusotine and ACTH Antagonist Development Programs at European Congress of Endocrinology
finance.yahoo.com - September 4 at 12:18 PM |
| Crinetics Pharmaceuticals to Participate in September Investor Conferences
finance.yahoo.com - September 3 at 8:43 PM |
| Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 9:05 AM |
 | BRIEF-Crinetics Pharmaceuticals Receives Orphan Drug Designation For Paltusotine
www.reuters.com - July 8 at 6:24 PM |
| Crinetics Pharma's paltusotine an Orphan Drug in U.S. for growth hormone disorder
seekingalpha.com - July 8 at 6:24 PM |
| Should You Avoid Crinetics Pharmaceuticals, Inc. (CRNX)?
finance.yahoo.com - July 5 at 7:07 PM |
 | Crinetics Pharmaceuticals Inc
www.bloomberg.com - June 30 at 7:10 PM |
| Analysts' Revenue Estimates For Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Are Surging Higher
finance.yahoo.com - June 30 at 9:09 AM |
| Analysts' Revenue Estimates For Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Are Surging Higher
finance.yahoo.com - June 30 at 9:09 AM |
| Crinetics Pharmaceuticals, Inc. (CRNX) Shares March Higher, Can It Continue?
finance.yahoo.com - June 19 at 2:21 PM |
| BRIEF-Crinetics Confirms Completion For Half Of Enrolled Patients In Ongoing Phase 2 Acrobat Edge Clinical Trial For Paltusotine
in.reuters.com - June 11 at 6:03 PM |
| Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine
finance.yahoo.com - June 11 at 8:02 AM |
 | Crinetics Pharmaceuticals Appoints Adriana Cabre, MBA, as Vice President of Human Resources
www.marketwatch.com - May 27 at 12:12 PM |
| Crinetics Pharmaceuticals Appoints Adriana Cabré, MBA, as Vice President of Human Resources
finance.yahoo.com - May 27 at 12:12 PM |
